Evidence map›Paper›PMID 39669277›Full record

ArticleFrontiers in cellular and infection microbiology2024

The prognostic value of neutrophil-to-lymphocyte ratio in adult carbapenem-resistant

Zhongjie Wang, Renhua Li, Zhe Yuan, Zuli Zhang, Keli Qian

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Zhongjie WangDepartment of Infection Control, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Renhua LiDepartment of Infection Control, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Zhe YuanDepartment of Infection Control, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Zuli ZhangDepartment of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Keli QianDepartment of Infection Control, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Systemic inflammatory indicators such as neutrophil-to-lymphocyte ratio (NLR) can effectively predict the prognosis of various inflammatory diseases. However, its prognostic effect on patients with carbapenem-resistant Methods: A total of 190 inpatients with CRKP infection from 1 January 2023 to 31 December 2023 were enrolled in this study, namely, 73 fatal cases and 117 survival cases in hospital. The medical data and examination results of these patients were collected. A logistic regression analysis was performed to assess the association between the NLR on the day of CRKP infection onset and all-cause mortality in hospital. Results: The overall mortality rate of patients with CRKP infection was 38.42% (73/190). Of the 190 patients, 91 were co-infected with carbapenem-resistant Conclusions: The NLR on the day of CRKP infection onset, admission to an ICU, and co-infection with CRAB/CRPA were identified as independent risk factors for all-cause mortality of patients with CRKP infection, while appropriate treatment within 3 days was recognized as an independent protective factor. The NLR serves as a conveniently accessible and independent prognostic biomarker for patients with CRKP infection.

Indexed as

CarbapenemsKlebsiella InfectionsKlebsiella pneumoniaeLymphocytesNeutrophilsAcinetobacter baumanniiAdultAgedAnti-Bacterial AgentsCarbapenem-Resistant EnterobacteriaceaeCoinfectionFemaleHumansMaleMiddle AgedPrognosisAnti-Bacterial AgentsCarbapenemscarbapenem-resistant Klebsiella pneumoniaeco-infectionneutrophil-to-lymphocyte ratioprognosisrisk factors

Identifiers

PMID39669277
PMCPMC11634867

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.